Waleed H. Hassanein, President & CEO at TransMedics Group, Inc. (TMDX), sold 16,950 shares at $145.54 ($2.5M) on 2024-07-15, disclosed to the SEC on 2024-07-17.
Scheduled sale ($2.5M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $143.61 | 1,397 | $201K | 8.2% |
| 2 | $143.61 | 1,397 | $201K | 8.2% |
| 3 | $144.34 | 2,540 | $367K | 14.9% |
| 4 | $144.34 | 2,540 | $367K | 14.9% |
| 5 | $145.54 | 2,046 | $298K | 12.1% |
| 6 | $145.54 | 2,046 |
| $298K |
| 12.1% |
| 7 | $146.39 | 2,342 | $343K | 13.9% |
| 8 | $146.39 | 2,342 | $343K | 13.9% |
| 9 | $147.28 | 300 | $44K | 1.8% |
| Total | $145.13 avg | 16,950 | $2.5M | 100% |
| Filing → |
| TMDX | SELL | 2024-10-17 | $2.1M | — | Filing → |
| TMDX | SELL | 2024-09-17 | $2.6M | — | Filing → |
| TMDX | SELL | 2024-08-23 | $7.8M | — | Filing → |